Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05608421 · ClinicalTrials.gov registry record · NA

1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV

A NA study of HIV and Medication Adherence, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05608421: Recruiting NA study of HIV and Medication Adherence, sponsored by Johns Hopkins University.

NCT05608421 is a NA study of HIV and Medication Adherence that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 100 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05608421, a NA study of HIV and Medication Adherence, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study tests a 5-session cognitive behavioral approach program (herein referred to as the 1MoreStep intervention) to train Black women living with HIV (BWLWHI) and exposed to intimate partner violence (IPV) in the past 2 years (hereafter, BWLWHI) in: 1) cognitive and behavioral skills to access internal and external sources of strength (e.g. self-reliance, safety net); safety strategies, knowledge about Undetectable = Untransmissible (U=U) and HIV care; and reduce internalized and anticipated stigma; 2) communication skills to respond to enacted HIV and IPV stigma and enlist social support; and 3) addressing structural barriers to HIV care engagement with an HIV navigator component. The intervention is informed by the HIV-Stigma Framework and a resilient-reintegration model which views women as active participants in responding to IPV and managing life with HIV. Aim 1: Examine preliminary efficacy of the 1MoreStep intervention on: (a) IPV safety strategies (informal and formal resources, safety planning, and placating strategies at baseline, 3-month and 6-month follow-up visits); and (b) HIV care engagement (medical record confirmed visit with an HIV care provider, antiretroviral therapy (ART) prescription, medication adherence, and viral load status during 3-month and 6-month follow-up visits). Aim 2: Examine the acceptability and feasibility of the 1MoreStep intervention operationalized by (a) quantitative measures: session attendance and fidelity to key intervention components and (b) qualitative interviews to assess: program fit, facilitators and barriers to participation, and using 1MoreStep intervention skills.

Primary Outcome

This scale has scores that range from 8 to 40. Low acceptability scores will be between 8 and 24, and high acceptability scores will be between 17 and 40.

Interventions

  • BEHAVIORAL 1MoreStep
  • BEHAVIORAL 1MoreStepControl

Study Locations (1)

Maryland

  • Johns Hopkins School of Nursing - Baltimore

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-06-26
Est. Completion 2026-12
Phase NA
Johns Hopkins University

1,448 total trials

What NCT05608421 shows while recruiting

NCT05608421 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 440-participant average among 303 other HIV trials with a reported enrollment target (77% lower).

The record links to 5 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which 1MoreStep is the first listed.

NCT05608421 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT05608421 about?

NCT05608421 is a clinical study titled "1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV". This study tests a 5-session cognitive behavioral approach program (herein referred to as the 1MoreStep intervention) to train Black women living with HIV (BWLWHI) and exposed to intimate partner violence (IPV) in the past 2 years (hereafter, BWLWHI) in: 1) cognitive and behavioral skills to access ...

What is the current status of trial NCT05608421?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-06-26. Estimated completion is 2026-12.

What conditions does trial NCT05608421 study?

This clinical trial studies the following conditions: HIV, Medication Adherence, Stigma, Social, Violence, Domestic, Engagement, Patient.

What interventions are being tested in trial NCT05608421?

The interventions under investigation include: 1MoreStep (BEHAVIORAL), 1MoreStepControl (BEHAVIORAL).

Who is sponsoring clinical trial NCT05608421?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05608421 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05608421's enrollment target sits among peer trials

100 150th of 303 higher than 142 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

  • NCT01773278 · 100 participants · Phase 2

    Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05608421, the US trial registry maintained by the National Library of Medicine. NCT05608421 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.